Đang chuẩn bị liên kết để tải về tài liệu:
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer

Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohistochemistry (IHC) is often used as screening tool in clinical practice. |